These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 16203264

  • 1. [Micro-RNA and oncogenesis].
    Bénard J, Douc-Rasy S.
    Bull Cancer; 2005 Sep; 92(9):757-62. PubMed ID: 16203264
    [Abstract] [Full Text] [Related]

  • 2. A DNA microarray screen for genes involved in c-MYC and N-MYC oncogenesis in human tumors.
    Schuldiner O, Benvenisty N.
    Oncogene; 2001 Aug 16; 20(36):4984-94. PubMed ID: 11526483
    [Abstract] [Full Text] [Related]

  • 3. c-Myc-regulated microRNAs modulate E2F1 expression.
    O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT.
    Nature; 2005 Jun 09; 435(7043):839-43. PubMed ID: 15944709
    [Abstract] [Full Text] [Related]

  • 4. [Oncogenic and tumour suppressor microRNAs].
    Finoux AL, Chartrand P.
    Med Sci (Paris); 2008 Dec 09; 24(12):1049-54. PubMed ID: 19116113
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells.
    Chan JA, Krichevsky AM, Kosik KS.
    Cancer Res; 2005 Jul 15; 65(14):6029-33. PubMed ID: 16024602
    [Abstract] [Full Text] [Related]

  • 8. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells.
    Sampson VB, Rong NH, Han J, Yang Q, Aris V, Soteropoulos P, Petrelli NJ, Dunn SP, Krueger LJ.
    Cancer Res; 2007 Oct 15; 67(20):9762-70. PubMed ID: 17942906
    [Abstract] [Full Text] [Related]

  • 9. [RNA interference and molecular pathology of selected diseases].
    Lochmanová J, Bartos M.
    Cas Lek Cesk; 2008 Oct 15; 147(12):607-15. PubMed ID: 19235485
    [Abstract] [Full Text] [Related]

  • 10. [Great potential of small RNAs: RNA interference and microRNA].
    Vázquez-Ortiz G, Piña-Sánchez P, Salcedo M.
    Rev Invest Clin; 2006 Oct 15; 58(4):335-49. PubMed ID: 17146945
    [Abstract] [Full Text] [Related]

  • 11. [Progress of miRNA and its functions in eukaryotes].
    Ma ZL, Yang HY, Tien P.
    Yi Chuan Xue Bao; 2003 Jul 15; 30(7):693-6. PubMed ID: 14579542
    [Abstract] [Full Text] [Related]

  • 12. Silencing of MBD1 and MeCP2 in prostate-cancer-derived PC3 cells produces differential gene expression profiles and cellular phenotypes.
    Yaqinuddin A, Abbas F, Naqvi SZ, Bashir MU, Qazi R, Qureshi SA.
    Biosci Rep; 2008 Dec 15; 28(6):319-26. PubMed ID: 18666890
    [Abstract] [Full Text] [Related]

  • 13. RNAi, microRNAs, and human disease.
    Hammond SM.
    Cancer Chemother Pharmacol; 2006 Nov 15; 58 Suppl 1():s63-8. PubMed ID: 17093929
    [Abstract] [Full Text] [Related]

  • 14. p53 enters the microRNA world.
    Hermeking H.
    Cancer Cell; 2007 Nov 15; 12(5):414-8. PubMed ID: 17996645
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. miR-21 as a key regulator of oncogenic processes.
    Selcuklu SD, Donoghue MT, Spillane C.
    Biochem Soc Trans; 2009 Aug 15; 37(Pt 4):918-25. PubMed ID: 19614619
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.